Ruti Aga: Six Years, and a Prescription From a Clinic That Never Existed

The prescription carried a clinic's name at the top. Below it were the signatures of a doctor, the name of a drug, and a date. When the verification began, three things fell apart in sequence. The clinic had never existed at that address. The person who signed had no medical registration. And the form on which the drug was written had come off an old pad from a former workplace — a pad the clinic itself disowned, because there was no clinic to own it. The Athletics Integrity Unit (AIU) recorded this entire chain in a short statement. I read that statement three times, because in documents of this kind, the loudest thing is usually the thing left unwritten. Ruti Aga is 32. An Ethiopian marathoner. Winner of the 2026 Tokyo Marathon. Three second-place finishes at World Marathon Majors. The race at which her sample was collected was a half marathon in China in March, and she won it. She is now suspended for six years — from 10 September, the same date her provisional suspension began. At the end of it, she will be 38. No Ethiopian selector will have a reason to place a 38-year-old with a doping record into a national team, given the depth available in that country's women's marathon. Start with the number that receives the least space in this story and carries the most weight — the sanction arithmetic. Two years for the presence violation. Four years for tampering. The sum is six. That arithmetic is itself a finding: the panel accepted that a prohibited substance was in her body, and then decided that the attempt to disguise it should cost three times what the substance alone would have cost. The two-year figure also tells us the panel did not place her in the "no significant fault" bracket, which would have reduced it further. And the four-year figure tells us tampering was treated as fully culpable, not partially. Now the fact nearly every report got wrong. Methylprednisolone was described as a "prohibited steroid" and as being "classed as performance enhancing by WADA." That is technically incorrect. Methylprednisolone is a glucocorticoid — WADA Prohibited List class S9 — not an anabolic steroid, which sit in class S1. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes. A therapeutic knee injection administered out-of-competition is entirely lawful. It becomes a violation only when residues are present during the in-competition window. That single sentence reverses the entire case. The argument was never "did she take a steroid." The argument was route and timing. This is where the case moves past interesting. In a road race, the testing window opens at 23:59 the day before the race. So an athlete who receives a knee injection four days out, and whose metabolite has not cleared by race morning, is inside the rules' reach — even though the injection was legitimate and necessary. The answer to that is not concealment. The answer is a team physician who keeps a dated log of dose, route and washout relative to the competition calendar, or a Therapeutic Use Exemption application. Aga appears to have had neither structure. The "doctor" who wrote the prescription was a family member, not a registered practitioner. The clinic printed at the top of the form did not exist at that address. This is not a filing error. This is the signature of an athlete operating without a credentialed medical team — and when she was caught, she tried to build the document, because the document was what she lacked. What interests me most about this case is that the genuine achievement survives. The violation attaches to that March race, and absent a finding of earlier use, results before that date are not automatically annulled. The 2026 Tokyo title stays. The three Major second places stay. What goes is the result and prize money from the Chinese half marathon, and ranking points accrued from that date. The AIU statement does not spell this out; I am writing it as an inference from standard practice, not as a fact. Now the part I have been building data around since 2026. Before the London World Championships I spent six weeks on one spreadsheet — every qualifying standard, every Indian entrant's season's best, personal best, and the gap in centimetres or seconds. That sheet taught me that a preview is written from a spreadsheet, not from memory. Applying the same logic here, a question becomes necessary: what was the time in that March half marathon? How strong was the field? What was her season's best? The source contains none of it. So I will not offer a performance judgement. I will record only that she won — which implies a World Athletics Label-tier elite field, with out-of-competition and in-competition testing present. Without that testing, this case would not exist. In 2026, in Russia, I was the only woman in my outlet's VAR verification room. I learned who sees which frame, in what order, and on whose sign-off. I carried that protocol straight into athletics. The 86.47m javelin gold at Gold Coast, the 88.06m at Jakarta, Hima Das's 400m national record — behind each number I wrote the chain: measurement, wind gauge, timing system, doping sample. In the verification room the truth arrived in frames; on the track it arrived in breath. Aga's case should be read from the other end of that chain. The question is not whether the sample was sound. The question is who built the paperwork after it. That is where the economic picture begins, and the source never touches it. A large share of East African road runners' income is appearance fees — racing the Asian label circuit between Majors, winning, collecting, returning. The Chinese half marathon circuit is the cleanest example of the model: big budgets, deep Ethiopian and Kenyan elite fields, fast recovery races. For a 2:18–2:20 marathoner, it is a low-risk, quick-cash tier. It is also now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding inside the same races. Where the money is densest, the samples are densest. That is not coincidence; it is design. In 2026, when the season collapsed — Diamond League meets cancelled, Tokyo postponed on 24 March, the national camp at Patiala sealed — I spent eleven weeks on the phone instead of in a stadium. I logged the lockdown conditions of 43 Indian athletes: who still had a track, who had a Railways job to fall back on, who had stopped training entirely. That long read opens on empty stands, and its real subject is what the sports-quota economy looks like when competition stops. Eleven weeks of phone calls taught me more than a season of press conferences. Apply that scale here. An Indian athlete has a Railways or Services sports-quota post, TOPS funding, a Khelo India scholarship, a state cash award. A ban stops the race income; it does not stop the salary. An Ethiopian road runner has none of those pillars. She has a race, an agent, and a training group. A ban takes all three at once. I think the informal medical networks grow out of exactly that absence. When there is no budget line for a team doctor, a family member becomes the doctor. And when there is a fear of being caught, an old pad becomes useful. One further detail should not be glossed. The four-year tampering sanction does not rest on the document alone — it came from an interview. From statements made under questioning. Language and translation conditions in AIU interviews with East African athletes have been a recurring point of contention. That does not reduce the sanction, but it tells us where the case began. When an athlete is asked where the prescription came from, and she answers, the answer becomes the basis of the next charge. Protocol is memory written down — which is why institutions fear it, and why the attempt to rewrite what has already been written is the most expensive move available. The sanction architecture is standard, not exceptional. Two years on presence — consistent with a specified substance finding without proven intent. Four years on tampering — the Code's standard. Six in total. Backdating to 10 September is not relief; provisional suspension time counts against the ban, so the real gain is zero. A CAS appeal window exists, typically around 21 days from the reasoned decision, but a document-based tampering finding is hard to overturn. Now the question nobody asked, and the one that matters. Six years has been imposed for a substance with no proven endurance benefit. A glucocorticoid reduces pain and inflammation; it does not raise red-cell count, it does not build muscle. The sanction is this heavy because the offence was not the drug. The offence was the lie. And under the Code, the lie always costs more than the drug. That is coherent. But it is also true that if Aga had had a credentialed team physician, this case might never have existed. The real failure is not in the prescription. It is in the absence of the support structure nobody was providing. The AIU investigates, sanctions, and closes the file. It does not hand anyone a doctor. A comparison is worth making carefully. India's javelin belt — Haryana, Punjab, western Uttar Pradesh, where akhada lineage meets imported biomechanics — still rests on a PSU quota. Kerala's middle-distance conveyor does too. In both, responsibility for the athlete is distributed across family, state and federation. In East African road running, that responsibility sits entirely with an agent and a training camp, which have no appointment standard and only a profit calculation. That difference is structural, not moral. And structure decides whose door an athlete knocks on when the knee goes. There is a technical gap in this story that should be filled. The year of the March race is not stated, nor is the ban's end date. The statement says "Thursday," and says "provisionally suspended since 10 September" — both imply the current year, they do not establish it. For a forensic report, that is a deficiency, and I am recording it as a deficiency rather than filling it with a guess. What has changed most is not detection technology. The sample system is the same. The change is that the enforcement frontier has moved from detection to document verification. The old question was: was the substance there? The new question is: is the paper you produced real? Across East African road-running cases, the second question is delivering sanctions faster than the first, because it requires no scientific argument — only a phone call and a registry check. The clinic not existing at that address is a fact. The doctor not being registered is a fact. The pad not being genuine is a fact. Three facts, three separate checks, one conclusion. In 2026, covering Tokyo remotely from Chicago — denied a credential under the pandemic cap — I had the analytical spine of the piece built before the medal ceremony on 7 August, after Neeraj Chopra's 87.58m. The pipeline from Panipat akhadas to imported biomechanics. I rebuilt the splits table twice and filed three hours past my own deadline. The lesson of that night was that a result is not the end of an analysis; it is the second act. The same logic applies here. The six-year ban is not the end of this story. The end is the question of why a 32-year-old standing at the economic summit of road racing had no doctor, and why she believed an old pad could stand in for one. The matrix said London was ready; I asked who wrote the matrix. Here the prescription said the treatment happened. I am asking who wrote it, and when the lights were last switched on at that clinic. The answers are the same: nobody, and never. One last point about the side that is easiest to forget. In Ethiopian women's marathon, the removal of a 2:18 performer does not move a single piece of national selection. The depth is such that three names fill one. But a ban does not only kill one athlete. It sends a message to an entire economy in which hundreds of women are racing without a team physician — and the message is not "hire a doctor." The message is "you will be caught." The distance between those two sentences will determine what the next story is about. The 2028 cycle will run without Aga; that is settled. The open question is whether, by 2028, some training camp will keep a paper register recording every injection, every date, every signature — and whether the AIU will treat that register as a verification instrument rather than a prosecution exhibit. Until that register exists, every knee injury is a potential tampering, and every old pad a potential exhibit. Protocol is memory written down. Whoever does not write it down cannot insure their own memory — athlete or institution.